Discontinued — last reported Q4 '25
Merck & Co. Animal Healthsegment — Depreciation decreased by 4.9% to $78.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 69.6%, from $46.00M to $78.00M. Over 4 years (FY 2021 to FY 2025), Animal Healthsegment — Depreciation shows an upward trend with a 15.6% CAGR.
An increase often signals significant capital investment in new manufacturing or research facilities, while a stable or decreasing trend may suggest aging infrastructure or a shift toward asset-light operations.
This metric represents the systematic allocation of the cost of tangible assets, such as manufacturing facilities, labor...
Comparable to depreciation and amortization charges reported by other capital-intensive pharmaceutical or manufacturing segments.
mrk_segment_animal_health_depreciation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.50M | $39.50M | $39.50M | $44.25M | $44.25M | $44.25M | $44.25M | $49.50M | $49.50M | $49.50M | $49.50M | $58.00M | $67.00M | $85.00M | $46.00M | $60.00M | $62.00M | $82.00M | $78.00M |
| QoQ Change | — | +0.0% | +0.0% | +12.0% | +0.0% | +0.0% | +0.0% | +11.9% | +0.0% | +0.0% | +0.0% | +17.2% | +15.5% | +26.9% | -45.9% | +30.4% | +3.3% | +32.3% | -4.9% |
| YoY Change | — | — | — | — | +12.0% | +12.0% | +12.0% | +11.9% | +11.9% | +11.9% | +11.9% | +17.2% | +35.4% | +71.7% | -7.1% | +3.4% | -7.5% | -3.5% | +69.6% |